Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot study

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|20|2|438-442

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.20, Iss.2, 2018-02, pp. : 438-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preperitoneal fat as a non‐invasive marker of increased risk of severe non‐alcoholic fatty liver disease in patients with type 2 diabetes

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 2, 2018-02 ,pp. : 511-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E42-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: A randomized controlled study

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E22-E29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical approach to non‐alcoholic fatty liver disease in patients with diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 9, 2015-09 ,pp. : 1121-1133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liraglutide for NASH/NAFLD

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite